Hong Luo

Title: Innovations of Hong Luo in Genetic Engineering

Introduction

Hong Luo is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of genetic engineering, particularly in the development of genetically engineered cells. His work focuses on creating innovative solutions for medical applications, especially in the treatment of tumors and pathogens.

Latest Patents

Hong Luo holds a patent for a genetically engineered cell that expresses an exogenous receptor specifically binding to a target antigen and exogenous CCL21. This cell is capable of further expressing an IL-7R binding protein or exogenous IL-7, which promotes cell proliferation. The patent also includes an expression construct comprising an exogenous CCL21 expression cassette, a vector containing the same, a virus, and a pharmaceutical composition that incorporates the engineered cell. This invention has potential applications in the preparation of drugs aimed at inhibiting tumors or pathogens.

Career Highlights

Hong Luo is associated with Crage Medical Co., Limited, where he continues to advance his research and development efforts. His innovative work has positioned him as a key figure in the field of genetic engineering, contributing to the development of therapies that could significantly impact patient care.

Collaborations

Hong Luo has collaborated with notable colleagues, including Zonghai Li and Hua Jiang. These partnerships have fostered a collaborative environment that enhances the research and development of groundbreaking medical technologies.

Conclusion

Hong Luo's contributions to genetic engineering exemplify the potential of innovative research in medicine. His patented work on genetically engineered cells represents a significant advancement in the fight against tumors and pathogens.